Where is Yosemite located?

Yosemite is headquartered in San Francisco, United States.

How many employees does Yosemite have?

As of Jul 31, 2026, the latest employee count at Yosemite is 49.

Where does Yosemite rank among its competitors?

Yosemite ranks 77th amongst 293 active competitors, of which 110 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Lyell Immunopharma, which secured $100M in Jul, 2025.

Who are the top competitors of Yosemite?

Yosemite's top competitors include Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics. Among them, Lyell Immunopharma secured the most recent funding round in July, 2025.

Yosemite - 2026 Company Profile & Competitors

Yosemite is an unfunded company based in San Francisco (United States). It operates as a Developer of therapies focused on transforming cancer into a non-lethal condition. Yosemite has not raised any funding yet. The company has 293 active competitors, including 110 funded and 62 that have exited. Its top competitors include companies like Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics.

Company Details

Developer of therapies focused on transforming cancer into a non-lethal condition. It is dedicated to researching and creating treatments to manage the disease. The company aims to improve patient outcomes through its therapeutic developments.

Website: yosemite.co
Email ID: *****@yosemite.co
Phone Number: +1 **********

Key Metrics

Location

San Francisco, United States

Stage

Unfunded

Ranked

77^th among 293 active competitors

Employee Count

49 as on Jul 31, 2026

Investment & Acquisitions

Chai Discovery & 15 more

Similar Companies

Abcellera Biologics & 381 more

View Yosemite's full profile

Yosemite has not raised any funding rounds yet.

Yosemite's employee count trend

Yosemite has 49 employees as of Jul 26. Here is Yosemite's employee count trend over the years:

Uncover Yosemite's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Yosemite include Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics. Here is the list of Top 10 competitors of Yosemite, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcellera Biologics 2012, Vancouver (Canada), Public	AI-enabled platform for antibodies discovery	$115M	DCVC, Orbimed & 16 others	71/100
2nd	Agios Pharmaceuticals 2008, Cambridge (United States), Public	Developer of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism	$120M	Arch Venture Partners, Flagship Pioneering ... & 6 others	70/100
3rd	TScan Therapeutics 1995, Boston (United States), Public	Developer of T cell therapies to harness the immune system against cancer	$180M	BlackRock, RA Capital Management & 9 others	70/100
4th	Beijing Jiakesi drug development 2015, Beijing (China), Public	Developer of small molecule based therapeutics for cancer treatment	$55M	Qiming Venture Partners, Lilly Asia Ventures ... & 3 others	66/100
5th	Boundless Bio 2018, San Diego (United States), Public	Developer of therapeutics for cancer by targeting ecDNA	$252M	RA Capital Management, Nextech Invest & 19 others	65/100
6th	Lyell Immunopharma 2018, San Francisco (United States), Public	Developer of CAR- T therapy for cancer treatment	$493M	Sahsen Ventures, GSK & 5 others	63/100
7th	ABL Bio 2016, Seongnam-si (South Korea), Public	Bi-specific antibodies and Antibody-drug Conjugate immunotherapies for oncology and neurodegenerative diseases	$65M	QUAD, Hana Financial Group & 7 others	63/100
8th	Cumulus Oncology 2017, Edinburgh (United Kingdom), Seed	Developer of therapies for treating cancers	$19.2M	Eos Advisory, Scottish Investment Bank & 26 others	61/100
9th	Black Diamond Therapeutics 2017, Cambridge (United States), Public	Developing MasterKey therapies to defeat cancer resistance and improve patient lives	$207M	New Enterprise Associates, Boxer Capital ... & 19 others	61/100
10th	Bolt Biotherapeutics 2015, Redwood City (United States), Public	Developer of T-cell therapies for the treatment of cancer	$177M	Pivotal bioVenture Partners, Nan Fung Life Sciences ... & 7 others	61/100
77th	Yosemite San Francisco (United States), Unfunded	Developer of therapies focused on transforming cancer into a non-lethal condition	-	-	45/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Yosemite's competitors? Click here to see the top ones

Yosemite has not made any acquisitions yet. Yosemite has made 16 investments.

Here is the list of latest three $investments:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 14, 2026	Investments	Chai Discovery	2023	San Francisco (United States)
Jun 22, 2026	Investments	HistoSonics	2009	Ann Arbor (United States)
Mar 17, 2026	Investments	Turquoise	2020	San Diego (United States)